Palantir's Order Book Is the Real Test of Its AI Story

Palantir shares climbed 4.2% in the previous session, riding a broad recovery across AI-related equities. Reuters attributed the improved mood to easing fears over tighter regulation of the AI industry in the United States. The advance followed eight consecutive losing sessions and a two-day selloff in the sector, though no single confirmed company-specific catalyst was cited for the move.

Barclays Lifts Its Target, JPMorgan Stays Bullish

Barclays raised its price target on Palantir on Wednesday to $273 from $265, reaffirming its "Overweight" rating. The bank adjusted its target but left its investment verdict unchanged.

JPMorgan had already initiated coverage on October 29 with an "Overweight" rating, setting a price target of $262 for December 2027 and adding Palantir to its "Analyst Focus List." That selection accompanied the launch of the firm's coverage.

Those optimistic calls sit alongside doubts about how durable AI growth really is. According to media reports, largely unchanged order backlogs compared with the prior quarter, plus closer scrutiny of growth prospects, weighed on sentiment after the earnings release. Better-than-expected revenue and profits did not prevent the subsequent share-price decline.

Revenue Is Racing, Backlog Is Stalling

The central test is the development of the order book. For the bullish case to hold, Palantir would need to show that demand extends beyond projects already underway. A renewed acceleration in that backlog would support the expectation that customers are expanding their AI usage and committing to further work.

The starting point is demanding. Palantir reported third-quarter 2026 revenue of $2.313 billion on Monday, up 96% year over year. The faster the current business expands, the more important the question of follow-on orders becomes for investors.

Against that backdrop, a largely flat backlog carries extra weight. What matters for the valuation going forward is whether announced partnerships translate into additional business opportunities and, ultimately, into firm orders. Customer implementation is a key intermediate step along that path.

New Deployments Offer a Bullish Counterpoint

Supporting the optimistic reading is the partnership with Changshin announced on Thursday. According to the company, Foundry and AIP will be deployed in shoe development and manufacturing, linking development decisions with feedback from the factories. The collaboration aims to apply data and artificial intelligence across those operational processes, giving Palantir a concrete additional field of use for its platforms. Investors can watch whether new customer relationships broaden beyond single applications.

A second partnership announced Thursday, with AmeriLife, offers another reference point. Foundry and AIP are to be used in health and wealth distribution activities. At Crump Life Insurance Services, corresponding workflows are already in productive use, with broader rollout underway.

In the bullish scenario, these applications prove themselves in day-to-day operations and lay the groundwork for wider use. The ongoing rollout at AmeriLife would be a concrete point to watch. If customers bring additional processes on board and further orders follow, Palantir could ease doubts about the durability of its growth.

The Bar Is Highest in US Commercial

The bear case rests on the hitherto weak momentum in the order backlog. Should it persist, investors could increasingly view the high revenue growth rates as difficult to sustain. Successful individual projects might then carry less weight than the question of overall future demand.

The bar sits especially high in the US commercial business, where Palantir reported revenue growth of 148% year over year on Monday. For the full year, the company held out at least 143% growth in that segment.

Such expectations demand continued strong operational performance. The bearish scenario would therefore be a combination of still-high expectations and subdued order development. Even a successful technical rollout might only support the stock to a limited degree if it does not generate sufficiently broad additional demand.

What the Contracted Base Already Shows

Palantir's quarterly report for the third quarter of 2026, filed on Tuesday, offered further insight into its contracted business base. In it, the company put its remaining performance obligations as of September 30 at $4.9 billion.

As long as the new fields of use hold out the prospect of additional orders and customer adoption advances, a continuation of the growth trajectory remains plausible. If stagnation in the backlog instead becomes entrenched, skepticism about the durability of the AI business is likely to carry more weight.

The next concrete operational test is the broader rollout at AmeriLife, along with the announced implementation at Changshin. Progress could strengthen the positive case if it points to wider usage. For investors, the decision therefore extends beyond the latest sector recovery: what counts is whether growing application turns into a growing order book.